Research in mouse models of intestinal and lung cancer suggests that IL-7 enhances CD8+ T cell infiltration and suppresses myeloid-derived suppressor cells, boosting the efficacy of chemotherapy and immunotherapy (24). The gene discussed is CD8A; the disease is lung carcinoma.